TSC1 and neoplasm: Genetic settings with loss of the TSC tumor suppressors, leading to constitutively active mTORC1 signaling, together with the use of mTORC1 inhibitors such as rapamycin, have been particularly powerful in expanding our knowledge of mTORC1 functions and crosstalk regulation with other cellular pathways and processes.